123 related articles for article (PubMed ID: 28935847)
21. [Efficacy and peripheral immunity analysis of allogeneic natural killer cells therapy in patients with hepatocellular carcinoma].
Xie YB; Zhang JY; DU ML; Meng FP; Fu JL; Liu LM; Wang SS; Qu R; Lian F; Qiao F; Chen YL; Gao YY; Xu RN; Shi M; Wang FS
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):591-595. PubMed ID: 31209436
[TBL] [Abstract][Full Text] [Related]
22. Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.
Kuba A; Raida L
Mediators Inflamm; 2018; 2018():9451950. PubMed ID: 29785172
[TBL] [Abstract][Full Text] [Related]
23. The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.
Ren HG; Adom D; Paczesny S
Expert Rev Clin Immunol; 2018 May; 14(5):389-404. PubMed ID: 29629613
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers in chronic graft-versus-host disease: quo vadis?
Wolff D; Greinix H; Lee SJ; Gooley T; Paczesny S; Pavletic S; Hakim F; Malard F; Jagasia M; Lawitschka A; Hansen JA; Pulanic D; Holler E; Dickinson A; Weissinger E; Edinger M; Sarantopoulos S; Schultz KR
Bone Marrow Transplant; 2018 Jul; 53(7):832-837. PubMed ID: 29367715
[TBL] [Abstract][Full Text] [Related]
25. The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation.
Couban S; Wong PC; Schultz KR
Exp Hematol; 2019 Feb; 70():1-9. PubMed ID: 30428338
[TBL] [Abstract][Full Text] [Related]
26. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
27. CD56
Kariminia A; Ivison S; Ng B; Rozmus J; Sung S; Varshney A; Aljurf M; Lachance S; Walker I; Toze C; Lipton J; Lee SJ; Szer J; Doocey R; Lewis I; Smith C; Chaudhri N; Levings MK; Broady R; Devins G; Szwajcer D; Foley R; Mostafavi S; Pavletic S; Wall DA; Couban S; Panzarella T; Schultz KR
Haematologica; 2017 Nov; 102(11):1936-1946. PubMed ID: 28935847
[TBL] [Abstract][Full Text] [Related]
28. Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.
Couban S; Aljurf M; Lachance S; Walker I; Toze C; Rubinger M; Lipton JH; Lee SJ; Szer J; Doocey R; Lewis ID; Huebsch L; Howson-Jan K; Lalancette M; Almohareb F; Chaudhri N; Ivison S; Broady R; Levings M; Fairclough D; Devins G; Szwajcer D; Foley R; Smith C; Panzarella T; Kerr H; Kariminia A; Schultz KR
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1410-1415. PubMed ID: 27154847
[TBL] [Abstract][Full Text] [Related]
29. CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study.
Jaiswal SR; Zaman S; Nedunchezhian M; Chakrabarti A; Bhakuni P; Ahmed M; Sharma K; Rawat S; O'donnell P; Chakrabarti S
Cytotherapy; 2017 Apr; 19(4):531-542. PubMed ID: 28131632
[TBL] [Abstract][Full Text] [Related]
30. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.
Melve GK; Ersvaer E; Eide GE; Kristoffersen EK; Bruserud Ø
Front Immunol; 2018; 9():845. PubMed ID: 29770133
[TBL] [Abstract][Full Text] [Related]
31. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Schmitz N; Beksac M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szerm J; Bradstock K; Buzyn A; Schlegelberger B; Matcham J; Gratwohl A
Haematologica; 2005 May; 90(5):643-8. PubMed ID: 15921379
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.
Minculescu L; Sengelov H; Marquart HV; Ryder LP; Fischer-Nielsen A; Haastrup E
Front Immunol; 2021; 12():625165. PubMed ID: 33777007
[TBL] [Abstract][Full Text] [Related]
33. The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
Ding L; Zhu H; Yang Y; Yan HM; Zhang HH; Han DM; Wang ZD; Zheng XL; Liu J; Zhu L; Mei-Xue ; Guo ZK; Wang HX
Leuk Res; 2017 May; 56():13-20. PubMed ID: 28161606
[TBL] [Abstract][Full Text] [Related]
34. Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
Carnevale-Schianca F; Caravelli D; Gallo S; Coha V; D'Ambrosio L; Vassallo E; Fizzotti M; Nesi F; Gioeni L; Berger M; Polo A; Gammaitoni L; Becco P; Giraudo L; Mangioni M; Sangiolo D; Grignani G; Rota-Scalabrini D; Sottile A; Fagioli F; Aglietta M
Biol Blood Marrow Transplant; 2017 Mar; 23(3):459-466. PubMed ID: 28039079
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial.
Lee SJ; Logan B; Westervelt P; Cutler C; Woolfrey A; Khan SP; Waller EK; Maziarz RT; Wu J; Shaw BE; Confer D; Horowitz MM; Anasetti C
JAMA Oncol; 2016 Dec; 2(12):1583-1589. PubMed ID: 27532508
[TBL] [Abstract][Full Text] [Related]
36. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
